List of Figures
Figure 1: Number of Products under Development for Type1 diabetes (Juvenile Diabetes)
Figure 2: Number of Products under Development by Companies, Type1 diabetes (Juvenile Diabetes)
Figure 3: Number of Products under Development by Universities/Institutes, Type1 diabetes (Juvenile Diabetes)
Figure 4: Number of Products under Development for Type2 diabetes
Figure 5: Number of Products under Development by Companies, Type2 diabetes
Figure 6: Number of Products under Development by Universities/Institutes, Type2 diabetes
Figure 7: Number of Products under Development for Hyperinsulinemia
Figure 8: Number of Products under Development by Companies, Hyperinsulinemia
Figure 9: Number of Products under Development for Hyperglycemia
Figure 10: Number of Products under Development by Universities/Institutes, Hyperglycemia
Figure 11: Number of Products by Top 10 Targets, Type1 diabetes (Juvenile Diabetes)
Figure 12: Number of Products by Stage and Top 10 Targets, Type1 diabetes (Juvenile Diabetes)
Figure 13: Number of Products by Top 10 Mechanism of Actions, Type1 diabetes (Juvenile Diabetes)
Figure 14: Number of Products by Stage and Top 10 Mechanism of Actions, Type1 diabetes (Juvenile Diabetes)
Figure 15: Number of Products by Top 10 Routes of Administration, Type1 diabetes (Juvenile Diabetes)
Figure 16: Number of Products by Stage and Top 10 Routes of Administration, Type1 diabetes (Juvenile Diabetes)
Figure 17: Number of Products by Top 10 Molecule Types, Type1 diabetes (Juvenile Diabetes)
Figure 18: Number of Products by Stage and Top 10 Molecule Types, Type1 diabetes (Juvenile Diabetes)
Figure 19: Number of Products by Top 10 Targets, Type2 diabetes
Figure 20: Number of Products by Stage and Top 10 Targets, Type2 diabetes
Figure 21: Number of Products by Top 10 Mechanism of Actions, Type2 diabetes
Figure 22: Number of Products by Stage and Top 10 Mechanism of Actions, Type2 diabetes
Figure 23: Number of Products by Top 10 Routes of Administration, Type2 diabetes
Figure 24: Number of Products by Stage and Top 10 Routes of Administration, Type2 diabetes
Figure 25: Number of Products by Top 10 Molecule Types, Type2 diabetes
Figure 26: Number of Products by Stage and Top 10 Molecule Types, Type2 diabetes
Figure 27: Number of Products by Targets, Hyperinsulinemia
Figure 28: Number of Products by Stage and Targets, Hyperinsulinemia
Figure 29: Number of Products by Mechanism of Actions, Hyperinsulinemia
Figure 30: Number of Products by Stage and Mechanism of Actions, Hyperinsulinemia
Figure 31: Number of Products by Routes of Administration, Hyperinsulinemia
Figure 32: Number of Products by Stage and Routes of Administration, Hyperinsulinemia
Figure 33: Number of Products by Molecule Types, Hyperinsulinemia
Figure 34: Number of Products by Stage and Molecule Types, Hyperinsulinemia
Figure 35: Number of Products by Targets, Hyperglycemia
Figure 36: Number of Products by Stage and Targets, Hyperglycemia
Figure 37: Number of Products by Mechanism of Actions, Hyperglycemia
Figure 38: Number of Products by Stage and Mechanism of Actions, Hyperglycemia
Figure 39: Number of Products by Molecule Types, Hyperglycemia
Figure 40: Number of Products by Stage and Molecule Types, Hyperglycemia